|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
30 March 2015 |
|
Main ID: |
NCT00801541 |
|
Date of registration:
|
02/12/2008 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Characterization of Early Markers of Choroidal Neovascularization
CNV-Markers |
|
Scientific title:
|
Characterization of Early Markers of Choroidal Neovascularization in Fellow Eyes of Patients With AMD and CNV in One Eye. (CNV-Markers) |
|
Date of first enrolment:
|
December 2005 |
|
Target sample size:
|
60 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00801541 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Portugal
| | | | | | | |
|
Contacts
|
|
Name:
|
José Cunha-Vaz, MD PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Association for Innovation and Biomedical Research on Light and Image |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Written informed consent
- Age over 50 years
- Any race and any sex
- Clinical diagnosis of exudative AM;D in one eye (non-stud eye) and the presence of
the following characteristics in the second eye (study eye, eye to be treated):
- At least 5 or more intermediate (> 63 µm) or larger soft drusen AND/OR Confluent
drusen within 3000 µm of the fovea center
- Hyperpigmentation
Exclusion Criteria:
- History of medical condition that would preclude scheduled study visits
- History of ophthalmic disease in the study eye other than AMD
- Clinical signs of myopic retinopathy, or refraction higher than -8 diopter power.
- Intraocular surgery in the study eye within 60 days prior enrollement
- Evidence of past or present CNV in the study eye
Age minimum:
50 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Age-related Macular Degeneration
|
|
Primary Outcome(s)
|
|
Wet AMD development in the study eye.
[Time Frame: Single Visit]
|
|
Secondary ID(s)
|
|
CNTM326_A9010002
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|